Biotech Archives - Page 708 of 733

1 minute read

Duchenne Gene Therapy Firm Sarepta Therapeutics’ Earns 8% Price Target Hike From This Analyst

July 29, 1:53 PM

Earlier today, Sarepta Therapeutics Inc (NASDAQ:SRPT) announced that it would submit the marketing application and seek accelerated FDA approval for SRP-9001 in…

SRPT

1 minute read

AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate

By Vandana Singh

July 29, 1:46 PM

AstraZeneca Plc (NASDAQ: AZN) has removed a Moderna Inc (NASDAQ: MRNA)-partnered cardiovascular disease candidate from its phase 2 pipeline.

AZN

1 minute read

Novo Nordisk Once-Weekly Insulin Hits Primary Goals In In Two Phase 3 Trials

By Vandana Singh

July 29, 1:42 PM

Novo Nordisk A/S (NYSE:NVO) announced headline results from the ONWARDS 3 and ONWARDS 4 Phase 3a trials with once-weekly insulin icodec…

NVO

1 minute read

Enanta Shares Rise On Positive Data From Initial-Stage Covid Study

By Ragothaman Srinivasan

July 29, 11:32 AM

Enanta Pharmaceuticals (NASDAQ: ENTA) reported positive topline data from a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics (PK) of orally administered single and multiple ascending doses of EDP-235 in healthy adult subjects.

ENTA

1 minute read

Omeros Shares Climb As FDA Grants Orphan Drug Status To Blood Disorder Candidate

By Ragothaman Srinivasan

July 29, 10:06 AM

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Omeros Corporation’s (NASDAQ: OMER) lead asset OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).

OMER

1 minute read

AbbVie’s Q2 Sales Marginally Shy Of Wall Street Estimates, Confirms Annual Profit Outlook

By Vandana Singh

July 29, 8:35 AM

AbbVie Inc (NYSE:ABBV) reports Q2 adjusted EPS of $3.37, up 11.2% Y/Y and beating the consensus of $3.33. Overall sales…

ABBV

2 minute read

Adamis Pharmaceuticals Provides Update On Clinical Study Assessing Tempol For The Treatment Of COVID-19

By Benzinga Newsdesk

July 29, 7:31 AM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the Company's ongoing U.S. Phase 2/3 clinical trial to evaluate the safety and efficacy of Tempol as a treatment for COVID-19. The

ADMP

3 minute read

Apollo Endosurgery Highlights Publication In The Lancet Of Landmark Study For Endoscopic Sleeve Gastroplasty Procedure

By Bill Haddad

July 29, 7:03 AM

Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally

APEN

1 minute read

AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance

By Vandana Singh

July 29, 6:04 AM

AstraZeneca Plc (NASDAQ:AZN) Q2 profits fell sharply on ballooning costs linked to its Alexion takeover. The net profit was down…

AZN

2 minute read

Bausch Health To Appeal Expected Court Decision On Xifaxan Patents

By Vandana Singh

July 29, 5:01 AM

Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin).

BHC